Article
Genetic inhibition of CETP, ischemic vascular disease and mortality, and possible adverse effects.
Journal of the American College of Cardiology - 13 Nov 2012
Johannsen Trine Holm, Frikke-Schmidt Ruth, Schou Jesper, Nordestgaard Børge G, Tybjærg-Hansen Anne
Abstract excerpt
OBJECTIVES: This study tested whether genetic variation in the CETP gene is consistent with a protective effect of cholesteryl ester transfer protein (CETP) inhibition on risk of ischemic events and on total mortality, without the adverse effects reported for torcetrapib. BACKGROUND: Torcetrapib, an inhibitor of CETP, increased risk of death and ischemic cardiovascular disease of those randomized to the drug,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
